Published in Int J Tuberc Lung Dis on September 01, 2011
Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol (2001) 3.12
Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol (1999) 2.23
Should the 'bleach microscopy method' be recommended for improved case detection of tuberculosis? Literature review and key person analysis. Int J Tuberc Lung Dis (2004) 1.93
Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother (1988) 1.76
AIDS and Mycobacterium avium serovars in Sweden. Lancet (1989) 1.55
Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007. Int J Tuberc Lung Dis (2009) 1.52
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur J Clin Microbiol Infect Dis (2001) 1.45
Tenosynovitis of the hand caused by Mycobacterium terrae. Eur J Clin Microbiol Infect Dis (1989) 1.35
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data. J Antimicrob Chemother (2010) 1.34
Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis (1994) 1.33
Improved sputum microscopy for a more sensitive diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.33
Molecular epidemiological studies of Mycobacterium bovis infections in humans and animals in Sweden. J Clin Microbiol (1995) 1.33
Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs. Int J Tuberc Lung Dis (1998) 1.22
Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis. Clin Microbiol Infect (2003) 1.10
DNA fingerprinting of Mycobacterium tuberculosis strains from patients with pulmonary tuberculosis in Honduras. J Clin Microbiol (1997) 1.10
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tuber Lung Dis (1993) 1.03
Ethambutol: a key for Mycobacterium avium complex chemotherapy? Am Rev Respir Dis (1989) 1.01
Tuberculosis as an occupational hazard for health care workers in Estonia. Int J Tuberc Lung Dis (2001) 0.95
Does vaccination with bacille Calmette-Guérin protect against AIDS? Rev Infect Dis (1989) 0.92
Antimycobacterial synergism of clarithromycin and rifabutin. Scand J Infect Dis (1996) 0.91
Drug resistant tuberculosis in Estonia. Int J Tuberc Lung Dis (1998) 0.89
Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages. Infect Immun (1992) 0.89
Comparison of Mycobacterium avium complex (MAC) strains from pigs and humans in Sweden by random amplified polymorphic DNA (RAPD) using standardized reagents. Vet Microbiol (2001) 0.87
In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J Antimicrob Chemother (2001) 0.85
Mycobacterium fortuitum complex in Sweden during an 11-year period. Scand J Infect Dis (1997) 0.82
Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution. Scand J Infect Dis (2001) 0.82
Drug-resistant Mycobacterium tuberculosis and atypical mycobacteria isolated from patients with suspected pulmonary tuberculosis in Honduras. Chest (1997) 0.82
Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. Eur J Clin Microbiol Infect Dis (1992) 0.80
Increased growth of Mycobacterium malmoense in vitro in the presence of isoniazid. Eur J Clin Microbiol Infect Dis (1991) 0.80
Mycobacterium interjectum: a new pathogen in humans? Scand J Infect Dis (2000) 0.80
Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime. Diagn Microbiol Infect Dis (1997) 0.77
In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis (2002) 0.77
Are strains of Mycobacterium avium more drug resistant when isolated from human immunodeficiency virus-infected patients? J Infect Dis (1992) 0.75
Estimation of heat production by cultured cells in suspension using semi-automated flow microcalorimetry. Cytobios (1985) 0.75
Novel approaches to the diagnosis of mycobacterial infections. Eur Respir J (1994) 0.75
Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis (2009) 0.75
Tuberculosis in HIV-infected patients in Honduras. Int J Tuberc Lung Dis (1999) 0.75